BlackRock Fund Advisors’s Anavex Life Sciences AVXL Stock Holding History

BlackRock Fund Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4.19M	Buy	1,057,856 +171,797	+19%	+$612K	﹤0.01%	2997
2016 Q3	$3.22M	Buy	886,059 +36,642	+4%	+$154K	﹤0.01%	3047
2016 Q2	$5.19M	Buy	849,417 +843,994	+15,563%	+$4.08M	﹤0.01%	2780
2016 Q1	$27K	Buy	5,423 +1,549	+40%	+$6.81K	﹤0.01%	3873
2015 Q4	$22K	Buy	+3,874	New	+$27.6K	﹤0.01%	3953

Other funds holding AVXL

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Fund Advisors's AVXL Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Anavex Life Sciences (AVXL) stake by 19% in Q4 2016, buying an estimated $612K and bringing the position to 1,057,856 shares worth $4.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2997.

BlackRock Fund Advisors first reported a position in AVXL in Q4 2015 and has held it in 5 quarters since. The position peaked at $5.19M in Q2 2016. 59 funds tracked by Wall St. Rank hold AVXL as of Q4 2016.

BlackRock Fund Advisors held 1,057,856 shares of Anavex Life Sciences worth $4.19M as of Q4 2016.
BlackRock Fund Advisors bought 171,797 Anavex Life Sciences shares in Q4 2016, an estimated $612K.
Anavex Life Sciences made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2997 holding.
BlackRock Fund Advisors first reported a position in Anavex Life Sciences in Q4 2015 and has held it in 5 quarters since.
BlackRock Fund Advisors's Anavex Life Sciences position peaked at $5.19M in Q2 2016.
59 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.